1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
|
Director |
X |
10% Owner |
|
Officer (give title below) |
|
Other (specify below) |
|
|
|
|
|
1. Name and Address of Reporting Person*
THURGAUERSTRASSE 130, 8152 |
|
(Street)
Relationship of Reporting Person(s) to Issuer
|
Director |
X |
10% Owner |
|
Officer (give title below) |
|
Other (specify below) |
|
|
|
|
|
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
|
Director |
X |
10% Owner |
|
Officer (give title below) |
|
Other (specify below) |
|
|
|
|
|
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
|
Director |
X |
10% Owner |
|
Officer (give title below) |
|
Other (specify below) |
|
|
|
|
|
1. Name and Address of Reporting Person*
JUPITERSTRAAT 250, 2132 HK |
|
(Street)
Relationship of Reporting Person(s) to Issuer
|
Director |
X |
10% Owner |
|
Officer (give title below) |
|
Other (specify below) |
|
|
|
|
|
1. Name and Address of Reporting Person*
12-10, NIHONBASHI 2-CHOME, CHUO-KU |
|
(Street)
Relationship of Reporting Person(s) to Issuer
|
Director |
X |
10% Owner |
|
Officer (give title below) |
|
Other (specify below) |
|
|
|
|
|
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
|
Director |
X |
10% Owner |
|
Officer (give title below) |
|
Other (specify below) |
|
|
|
|
|
|
/s/ James Kehoe, Chief Financial Officer, Takeda Pharmaceutical Company Limited |
09/08/2017 |
|
/s/ Brett R. Budzinski, Attorney-in-Fact for Millennium Pharmaceuticals, Inc. |
09/08/2017 |
|
/s/ Brett R. Budzinski, Attorney-in-Fact for Takeda Pharmaceuticals U.S.A., Inc. |
09/08/2017 |
|
/s/ Brett R. Budzinski, Attorney-in-Fact for Takeda Pharmaceutical International AG |
09/08/2017 |
|
/s/ Brett R. Budzinski, Attorney-in-Fact for Takeda Pharma A/S |
09/08/2017 |
|
/s/ Brett R. Budzinski, Attorney-in-Fact for Takeda A/S |
09/08/2017 |
|
/s/ Brett R. Budzinski, Attorney-in-Fact for Takeda Europe Holdings B.V. |
09/08/2017 |
|
** Signature of Reporting Person |
Date |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. |
* If the form is filed by more than one reporting person,
see
Instruction
5
(b)(v). |
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |